Results 51 to 60 of about 6,849 (179)

Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)

Clinical &Experimental Ophthalmology, Volume 53, Issue 5, Page 523-528, July 2025.
ABSTRACT Background Intravitreal bevacizumab has been used off‐label to treat multiple ocular conditions for almost two decades. Reference bevacizumab, Avastin, was discontinued in Australia in 2021. A bevacizumab biosimilar, MVASI, was approved by the Therapeutic Goods Administration for the treatment of metastatic cancer in 2020.
Hanru Wang, Bobak Bahrami, Sonia Huang, Marzieh Tahmasebi Sarvestani, Sudha Cugati, Stewart Lake, Weng Onn Chan, Devaraj Supramaniam, Matthew Little   +8 more
wiley   +1 more source

Central Serous Chorioretinopathy Diagnosed by Emergency Practitioner‐Performed Ocular Point‐Of‐Care Ultrasonography

Australasian Journal of Ultrasound in Medicine, Volume 28, Issue 2, May 2025.
ABSTRACT Introduction Central serous chorioretinopathy (CSCR) is a common cause of acute, monocular vision loss amongst men aged 40–50 years. Diagnosis is typically multimodal, requiring advanced ophthalmic imaging. These techniques are not readily available in acute care settings.
Christian P. Pappas, Matthew Watson, Christopher Harrington, Katherine Masselos   +3 more
wiley   +1 more source

Ibudilast Protects Retinal Bipolar Cells From Excitotoxic Retinal Damage and Activates the mTOR Pathway

Glia, Volume 73, Issue 5, Page 905-927, May 2025.
Main Points Ibudilast, a MIF and PDE inhibitor, preserves the form and function of the retina, especially bipolar cells, during excitotoxic damage. Ibudilast upregulates multiple signaling pathways, including mTOR, in damaged Müller glia and bipolar cells.
Sumaya Hamadmad, Tyler Heisler‐Taylor, Sandeep Goswami, Evan Hawthorn, Sameer Chaurasia, Dena Martini, Diana Summitt, Ali Zatari, Rahaf Shalash, Misha Sohail, Elizabeth G. Urbanski, Kayla Bernstein, Julie Racine, Abhay Satoskar, Heithem M. El‐Hodiri, Andy J. Fischer, Colleen M. Cebulla   +16 more
wiley   +1 more source

Assistance of Artificial Intelligence in Diagnosis of Vitreoretinal Lymphoma on Optical Coherence Tomography

Advanced Intelligent Systems, Volume 7, Issue 4, April 2025.
The proposed artificial intelligence model, cross‐subject meta‐transfer learning, enables the automatic detection of vitreoretinal lymphoma (VRL) on optical coherence tomography images among 16 retinal diseases and conditions. This study provides an innovative solution to assist in the VRL diagnosis in real‐world clinical implementation, showing ...
Aidi Lin, Yuanyuan Peng, Tian Lin, Jun Dai, Jizhu Li, Tingkun Shi, Xixuan Ke, Xulong Liao, Danqi Fang, Man Chen, Huiyu Liang, Shirong Chen, Honghe Xia, Jingtao Wang, Zehua Jiang, Tao Li, Dan Liang, Shanshan Yu, Jing Luo, Ling Gao, Dawei Sun, Yih Chung Tham, Xinjian Chen, Haoyu Chen   +23 more
wiley   +1 more source

Enantiomorphic Rhegmatogenous Retinal Detachment

Asia-Pacific Journal of Ophthalmology, 2022
Amber Amar, Bhayana, Shorya Vardhan, Azad   +1 more
openaire   +2 more sources

Missed retinal breaks in rhegmatogenous retinal detachment

International Journal of Ophthalmology, 2016
To evaluate the causes and associations of missed retinal breaks (MRBs) and posterior vitreous detachment (PVD) in patients with rhegmatogenous retinal detachment (RRD).Case sheets of patients undergoing vitreo retinal surgery for RRD at a tertiary eye care centre were evaluated retrospectively.
Brijesh Takkar, Shorya Azad, Adarsh Shashni, Amar Pujari, Indrish Bhatia, Rajvardhan Azad   +5 more
openaire   +3 more sources

Long term results of pneumatic retinopexy

Clinical Ophthalmology, 2012
Amin F EllakwaMenoufiya University, Shibin el Kom, Al-Menoufiya, EgyptBackground: Rhegmatogenous retinal detachment is a commonly encountered retinal problem where rapid treatment can prevent irreversible vision loss.
Ellakwa AF
doaj  

Use of Autologous Conditioned Platelet Rich Plasma in the Surgery of Rhegmatogenous Retinal Detachment with Central and Peripheral Tears

Acta Biomedica Scientifica, 2019
Background. The method of the use of autologous conditioned platelet rich plasma is a promising method in the surgery of retinal pathology, particularly in the surgery of rhegmatogenous retinal detachment without the use of additional endolaser ...
D. G. Arsiutov
doaj   +1 more source

Combined rhegmatogenous and traction detachment associated with vasoproliferative tumor secondary to sickle cell retinopathy

American Journal of Ophthalmology Case Reports, 2016
Purpose: To report the surgical management of a combined rhegmatogenous and traction retinal detachment associated with a vasoproliferative tumor secondary to sickle cell retinopathy.
Qiancheng Wang, Shelley Day, Peter A. Nixon, Robert W. Wong   +3 more
doaj   +1 more source

Outcomes of short- versus long-acting gas tamponades in vitrectomy for rhegmatogenous retinal detachment

International Journal of Retina and Vitreous
Background In vitrectomy for rhegmatogenous retinal detachment, long-acting gas tamponades (LGT) such as C3F8 or C2F6 may improve surgical success rate due to their prolonged effect compared to a short-acting gas tamponade (SGT) with SF6.
Verena Schöneberger, Jeany Q. Li, Leonie Menghesha, Frank G. Holz, Friederike Schaub, Tim U. Krohne   +5 more
doaj   +1 more source